Randomized, Crossover Trial of Control-IQ Technology with a Lower Treatment Range and a Modified Meal Bolus Module in Adults, Adolescents, Children, and Preschoolers with Varying Levels of Baseline Glycemic Control
Diabetes Technol Ther. 2024 Nov 26. doi: 10.1089/dia.2024.0501. Online ahead of print. ABSTRACT Objective: We evaluated a modified version of Control-IQ technology with a lower …